Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gervois

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
European Journal of Immunology|July 1, 1992
Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytesM C Pandolfino, C Viret, N Gervois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Heterogeneity of biologic responses of melanoma-specific CTLJ F Fonteneau, E Le Dréan, S Le Guiner, et al.
Immunology|August 1, 1997
Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptidesL Toujas, J G Delcros, E Diez, et al.
Scientific Reports|October 4, 2018
Angiogenic Properties of 'Leukocyte- and Platelet-Rich Fibrin'Jessica Ratajczak, Tim Vangansewinkel, Pascal Gervois, et al.
Stem Cells International|May 16, 2019
Preconditioning of Human Dental Pulp Stem Cells with Leukocyte- and Platelet-Rich Fibrin-Derived Factors Does Not Enhance Their Neuroregenerative EffectPascal Gervois, Jessica Ratajczak, Esther Wolfs, et al.
Plos One|August 17, 2013
Angiogenic properties of human dental pulp stem cellsAnnelies Bronckaers, Petra Hilkens, Yanick Fanton, et al.
Journal of Medicinal Chemistry|September 3, 2010
Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognitionCéline Douat-Casassus, Oleg Borbulevych, Marion Tarbe, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patientsNathalie Labarrière, Marie-Christine Pandolfino, Nadine Gervois, et al.
European Journal of Immunology|September 1, 1994
Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitroY Guilloux, C Viret, N Gervois, et al.
European Journal of Immunology|January 31, 2003
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigensLydie Trautmann, Nathalie Labarrière, Francine Jotereau, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
European Journal of Immunology|July 1, 1992
Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytesM C Pandolfino, C Viret, N Gervois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Heterogeneity of biologic responses of melanoma-specific CTLJ F Fonteneau, E Le Dréan, S Le Guiner, et al.
Immunology|August 1, 1997
Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptidesL Toujas, J G Delcros, E Diez, et al.
Scientific Reports|October 4, 2018
Angiogenic Properties of 'Leukocyte- and Platelet-Rich Fibrin'Jessica Ratajczak, Tim Vangansewinkel, Pascal Gervois, et al.
Stem Cells International|May 16, 2019
Preconditioning of Human Dental Pulp Stem Cells with Leukocyte- and Platelet-Rich Fibrin-Derived Factors Does Not Enhance Their Neuroregenerative EffectPascal Gervois, Jessica Ratajczak, Esther Wolfs, et al.
Plos One|August 17, 2013
Angiogenic properties of human dental pulp stem cellsAnnelies Bronckaers, Petra Hilkens, Yanick Fanton, et al.
Journal of Medicinal Chemistry|September 3, 2010
Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognitionCéline Douat-Casassus, Oleg Borbulevych, Marion Tarbe, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patientsNathalie Labarrière, Marie-Christine Pandolfino, Nadine Gervois, et al.
European Journal of Immunology|September 1, 1994
Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitroY Guilloux, C Viret, N Gervois, et al.
European Journal of Immunology|January 31, 2003
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigensLydie Trautmann, Nathalie Labarrière, Francine Jotereau, et al.
Pageof 13